TENANTS

Archive | Resident Company News

NeuroPoint-logo

New Metabolic Biomarkers Open Door to Earlier Diagnosis, More Precise and Individualized Treatment of Children at Risk for Autism

NeuroPointDX presents further data from the Children’s Autism Metabolome Project at INSAR 2019 MADISON, WI (May 6, 2019): Continued analysis of samples from the Children’s Autism Metabolome Project (CAMP), the most comprehensive clinical study of metabolism in children who has autism spectrum disorder (ASD) conducted to date, has identified three new areas of metabolism that affect […]

Continue Reading
Exact Sciences 650 Forward DR.

Exact Sciences starts scouting for a third lab site, CEO Kevin Conroy says

Exact Sciences Corp. hasn’t finished building its second big laboratory building to process Cologuard tests for colorectal cancer but the Madison cancer diagnostics company already is planning for lab No. 3. And, in an unrelated move, Exact’s stock price topped $100 per share this week for the first time. Exact has “begun evaluating potential sites […]

Continue Reading
Mallinckrodt Ribbon Cutting

Expansion of Operations and Manufacturing Facility for StrataGraft® Regenerative Skin Tissue in Madison, Wis.

– Expanded state-of-the-art facility provides capacity for clinical and commercial development of StrataGraft, if approved – Investment marks Mallinckrodt’s continued commitment to clinical development and manufacturing in the Madison community STAINES-UPON-THAMES, United Kingdom, April 24, 2019 /PRNewswire/ — Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today celebrated the completion of its expanded […]

Continue Reading
Biz Plan Contest

From gunshot detection to medical breakthroughs, Biz Plan Contest finalists show state’s tech range

Twenty-five entries representing sectors as broad as social media, health technologies and innovations in products or services are competing in the finalist round of the 16th annual Wisconsin Governor’s Business Plan Contest. The contestants have survived two rounds of judging in the contest organized through the Wisconsin Technology Council and its sponsors and volunteers. “These […]

Continue Reading
Kevin Conroy

As Exact Sciences’ Sales Surge, CEO Reflects on 10-Year Turnaround

A decade ago, Kevin Conroy took the CEO job at Exact Sciences, a cancer diagnostic firm on the brink of death. Five years later, the FDA greenlit the company’s first product, Cologuard, which marked the first non-invasive, stool-based DNA screening test approved for detecting colorectal cancer. In the five years since then, Exact (NASDAQ: EXAS) says it has screened […]

Continue Reading
Kathleen-Sebelius

Exact Sciences appoints former Kansas governor, HHS secretary Sebelius to its board of directors

Exact Sciences Corp., the maker of the Cologuard take home colon cancer test and one of the largest public companies in Wisconsin, has appointed Kathleen Sebelius, the former governor of Kansas and Secretary of the U.S. Department of Health and Human Services, to its board of directors, the Madison company announced Tuesday. “Secretary Sebelius understands […]

Continue Reading
illumina

Could we soon be able to detect cancer in 10 minutes?

About seven years ago, researchers at the US DNA sequencing company Illumina started to notice something odd. A new blood test it ran on 125,000 expectant mothers looking for genetic abnormalities such as Down’s syndrome in their foetuses returned some extremely unexpected signals in 10 cases. Chillingly, it dawned on them that the abnormal DNA they were […]

Continue Reading